Crinetics Pharmaceuticals, Inc. Contract Liability (Deferred Revenue)
Crinetics Pharmaceuticals, Inc. (CRNX) had Contract Liability (Deferred Revenue) of $1.67 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-03
- 2026-06-30: Contract with Customer, Liability, Current $1.67M.
- 2026-03-31: Contract with Customer, Liability, Current $1.27M.
- 2025-12-31: Contract with Customer, Liability, Current $1.24M.
- 2024-12-31: Contract with Customer, Liability, Current $2.18M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $1.67M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.24M 10-Q · filed 2026-08-03 |
| 2024-12-31 | $2.18M 10-K · filed 2026-02-26 |